Our wide-ranging selection of world-class products and services covers multiple cancer types. By detecting the unique genetic mutations in patients, tumors are classified, predicted and evaluated for disease development. Genetron’s team of qualified professionals are also at hand to assist patients in tracking treatment progress from selecting targeted drugs and chemotherapy drugs, evaluating the efficacy of immunotherapy and dynamically monitoring drug resistance. These steps are crucial in the development and optimization of clinical treatment programs in order to achieve personalized diagnosis and treatment.
